<b>Conclusions:</b> Among the analysis groups in which the validation was conducted, it was demonstrated that urinary L-FABP holds potential as a predictor of renal function decline in patients with diabetes or hypertension who have a maintained eGFR. Here, FABP1 is linked to hypertensive disorder.